Yanbin Lao is an innovative drug hunter with over 19 years of experience in drug metabolism and pharmacokinetics. Currently serving as the Executive Director of ExploR&D Development Sciences at Eli Lilly and Company, Yanbin leads a team of translational scientists to support the company's portfolio from discovery to early development phases. Previously, Yanbin held several senior roles at Abbott Laboratories, AbbVie, and Bristol Myers Squibb, contributing to various therapeutic areas including oncology and immunology. Yanbin earned a Ph.D. in Medicinal Chemistry from the University of Minnesota and a Master's degree in the same field from Peking University.
This person is not in any teams
This person is not in any offices